Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • EU invests 30m to fight antimicrobial resistance
  • Policy / Pricing

EU invests 30m to fight antimicrobial resistance

Pharmaphorum

The EU has pledged 30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

Policy / PricingInfectious DiseaseRead full story

pharminent April 8, 2026 (Last updated: April 8, 2026)

Pharmaphorum

The EU has pledged 30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

Policy / PricingInfectious DiseaseRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: RoosterBio and MineBio team up to expand MSC solutions access in China
Next: List Price Reductions Will Deflate the Gross-to-Net Bubble-and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun)

Related Stories

  • Policy / Pricing

Decoding Medicare Advantage Coding Intensity

pharminent July 1, 2026
  • Policy / Pricing

UK partners with Eli Lilly on obesity plan

pharminent June 29, 2026
  • Policy / Pricing

EFPIA report adds to pressures on EU drug pricing policy

pharminent June 24, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.